Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vattay

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Molecular Cancer Therapeutics|August 5, 2020
The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal MelanomaFlorencia Rago, GiNell Elliott, Ailing Li, et al.
Science Translational Medicine|October 1, 2010
Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastomaSilvia Buonamici, Juliet Williams, Michael Morrissey, et al.
Journal of Medicinal Chemistry|October 20, 2018
Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant CancersJulien P N Papillon, Katsumasa Nakajima, Christopher D Adair, et al.
European Radiology|February 13, 2026
Association of high-risk CT coronary artery plaque features with major adverse cardiovascular events: a prespecified secondary analysis of the DISCHARGE trialBálint Szilveszter, Federico Biavati, Charlotte Sørum, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Molecular Cancer Therapeutics|August 5, 2020
The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal MelanomaFlorencia Rago, GiNell Elliott, Ailing Li, et al.
Science Translational Medicine|October 1, 2010
Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastomaSilvia Buonamici, Juliet Williams, Michael Morrissey, et al.
Journal of Medicinal Chemistry|October 20, 2018
Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant CancersJulien P N Papillon, Katsumasa Nakajima, Christopher D Adair, et al.
European Radiology|February 13, 2026
Association of high-risk CT coronary artery plaque features with major adverse cardiovascular events: a prespecified secondary analysis of the DISCHARGE trialBálint Szilveszter, Federico Biavati, Charlotte Sørum, et al.
Pageof 13